The insurability of nanomaterial production risk
Source abstract
Abstract
Without insurance the long-term sustainability of nanotechnology is questionable, but insurance companies are encumbered by their institutional memory of losses from the asbestos crisis and the absence of suitable actuarial models to measure the potential risks of nanotechnology. Here we propose a framework that supports the transfer of nanomaterial production risk to the insurance sector.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Insurance, Mortality, Demography, Risk Management · Insurance and Financial Risk Management
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (23)
Show source-provided references
1. Schoffski, O. & Wegener, A. G. The Geneva Papers on Risk and Insurance—Issues and Practice 24, 203–215 (2011).10.1111/1468-0440.00016 ↗
2. Ferguson, N. The Ascent of Money: A Financial History of the World (Penguin, 2008).
3. Roco, M. C., Mirkin, C. A. & Hersam, M. C. Nanotechnology Research Directions for Societal Needs in 2020: Retrospective and Outlook Vol. 1 (Springer, 2011).10.1007/978-94-007-1168-6 ↗
4. Mangematin, V. & Walsh, S. Technovation 32, 157–160 (2012).10.1016/j.technovation.2012.01.003 ↗
5. Kahan, D. M. et al. Nature Nanotech. 4, 87–90 (2008).10.1038/nnano.2008.341 ↗
6. Chatterjee, R. Environ. Sci. Technol. 43, 1240–1241 (2009).10.1021/es900041e ↗
7. Murashov, V. & Howard, J. Nature Nanotech. 4, 467–470 (2009).10.1038/nnano.2009.205 ↗
8. Malloy, T. F. ACS Nano 5, 5–12 (2011).10.1021/nn103480e ↗
9. Murashov, V. & Howard, J. (eds) Nanotechnology Standards Ch. 9, 209–238 (Springer, 2011).10.1007/978-1-4419-7853-0 ↗
10. Murashov, V., Schulte, P., Geraci, C. & Howard, J. Ind. Health 49, 280–296 (2011).10.2486/indhealth.MS1228 ↗
11. Hett, A. Nanotechnology: Small Matter, Many Unknowns (Risk Perception Series) (Swiss Reinsurance Company, 2004); http://go.nature.com/9Dk87t
12. Johnson, E., Kostic, B., Riswadka, A. & Trodella, K. Insight on Nanotechnology (Zurich Financial Services Group, 2009); http://go.nature.com/TUjuPB
13. Kostoff, R. et al. J. Nanopart. Res. 8, 301–321 (2006).10.1007/s11051-005-9035-8 ↗
14. Baxter, D. Nanotechnology: An Insurers Perspective (2008); http://go.nature.com/ZYiFgA
15. Nanotechnology CRO briefing Emerging Risks Initiative (Nanowerk, 2010); http://go.nature.com/vLPh2a
16. Monica, J. First Commercial Insurance Exclusion for Nanotechnology (Nanotechnology Law Report, 2008); http://go.nature.com/PylXW6
17. Fink, A. J. Proc. 2010 Nanotech Conf. 3, 583–586 (2010).
18. Zalk, D. M., Paik, S. Y. & Swuste, P. J. Nanopart. Res. 11, 1685–1704 (2009).10.1007/s11051-009-9678-y ↗
19. International Standards Organization ISO-TC229/TR11360:2010 Nanotechnologies—Methodology for the Classification and Categorization of Nanomaterials; http://go.nature.com/EaRazI
20. OECD The Impacts of Nanotechnology on Companies: Policy Insights from Case Studies (OECD Working Party on Nanotechnology, 2010); http://doi.org/cq88td
21. Singer, P. A., Salamanca-Buentello, F. & Daar, A. S. Issues Sci. Technol. 21, 57–64 (2005).
22. Heinemann, M. & Schäfer, H. Hum. Exp. Toxicol. 28, 407–411 (2009).10.1177/0960327109105149 ↗
23. Zhang, X. Q., Yin, L. H., Tang, M. & Pu, Y. P. Biomed. Environ. Sci. 24, 661–669 (2011).